VASO
In the last couple of weeks brought my VASO back in the .16's and under, after selling in the .20-.22 range. Here's why I like it again.
1) Should have blockbuster revenue growth comp next quarter, with the acquisition which we found out they are expecting some cost savings from this merger.
2) They earn 580k or so pro forma last quarter if they can do that if not better from q1- q3 going foward, and have their usual .02-.03 quarter in q4. They can earn .03-.05 going foward, and at a price of under .16 seems very cheap for a growing healthcare company.
Conclusion: I think VASO is a very attractive healthcare stock with enormous potential for growth, and cost savings. I think VASO is very cheap, and should be brought on weakness. I continue to believe VASO could easily double if not more over the next year in my opinion. All is just my opinion, and I could always be wrong though.
News 
Market Data 
Discover 
